dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Lenz, Heinz-Josef |
dc.contributor.author | Argilés Martinez, Guillem |
dc.contributor.author | Falcone, Alfredo |
dc.contributor.author | Limón, María Luisa |
dc.contributor.author | Yoshino, Takayuki |
dc.contributor.author | Lonardi, Sara |
dc.date.accessioned | 2021-04-16T10:16:32Z |
dc.date.available | 2021-04-16T10:16:32Z |
dc.date.issued | 2019-12 |
dc.identifier.citation | Lenz HJ, Argiles G, Yoshino T, Lonardi S, Falcone A, Limón ML, et al. Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses. Clin Colorectal Cancer. 2019 Dec;18(4):269-279. |
dc.identifier.issn | 1533-0028 |
dc.identifier.uri | https://hdl.handle.net/11351/5867 |
dc.description | QVRS; Nintedanib; Temps de deteriorament |
dc.description.sponsorship | This work was supported by Boehringer Ingelheim. Medical writing assistance, supported financially by Boehringer Ingelheim, was provided by Syneos Health Communications during the preparation of this manuscript. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Clinical Colorectal Cancer;18(4) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Qualitat de vida |
dc.subject | Medicaments - Administració |
dc.subject | Còlon - Càncer |
dc.subject.mesh | Quality of Life |
dc.subject.mesh | Colorectal Neoplasms |
dc.subject.mesh | /drug therapy |
dc.title | Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.clcc.2019.08.005 |
dc.subject.decs | calidad de vida |
dc.subject.decs | neoplasias colorrectales |
dc.subject.decs | /farmacoterapia |
dc.relation.publishversion | https://www.sciencedirect.com/science/article/pii/S1533002818305255 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Lenz HJ] Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Los Angeles, CA. [Argiles G] Servei d'Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Yoshino T] Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan. [Lonardi S] Phase 1 Trial Unit and Medical Oncology Unit 1, Istituto Oncologico Veneto IRCCS, Padova, Italy. [Falcone A] Department of Oncology, University of Pisa, Pisa, Italy. [Limón ML] Medical Oncology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain |
dc.identifier.pmid | 31628043 |
dc.identifier.wos | 000499098300016 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |